IMR Press / FBL / Volume 16 / Issue 8 / DOI: 10.2741/3903

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article
Allosteric activation of coagulation factor VIIa
Show Less
1 Haemostasis Biochemistry, Novo Nordisk A/S, Novo Nordisk Park, DK-2760 Maaloev, Denmark
Academic Editor:L. Vijaya Mohan Rao
Front. Biosci. (Landmark Ed) 2011, 16(8), 3156–3163;
Published: 1 June 2011

Coagulation factor VIIa (FVIIa) is present at subnanomolar concentration and represents a small percentage of the total amount of FVII in the circulation. FVIIa is poised to initiate blood clotting when it encounters its pivotal cofactor tissue factor (TF) which becomes exposed to blood upon vascular rupture. The requirement for complex formation with TF in order for FVIIa to express procoagulant activity ensures thrombin and fibrin generation at the right time and place. Thus TF acts as a guardian of safety of paramount importance to blood coagulation by providing localization to the site of injury and at the same time inducing maturation of zymogen-like free FVIIa to the active cofactor-bound enzyme. This review gives an account of the accumulated knowledge about the structure, function and TF dependence of FVIIa to arrive at a plausible allosteric mechanism by which TF induces maturation of the active conformation of FVIIa.

Back to top